Gonal-f RFF Purple Book BLA 021765

BLA number
021765
Proprietary names
Gonal-f RFF
Proper names
follitropin alfa
Applicant
EMD Serono, Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Gonal-f RFFfollitropin alfa351(a)37.5IUFor InjectionSubcutaneousSingle-Dose VialDiscVoluntarily Revoked2004-03-25
002Gonal-f RFFfollitropin alfa351(a)75IUFor InjectionSubcutaneousSingle-Dose VialDiscVoluntarily Revoked2004-03-25
003Gonal-f RFFfollitropin alfa351(a)150IUFor InjectionSubcutaneousSingle-Dose VialDiscVoluntarily Revoked2004-03-25

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-04-01U001Gonal-f RFF351(a)DiscEMD Serono, Inc.
2026-04-01U002Gonal-f RFF351(a)DiscEMD Serono, Inc.
2026-04-01U003Gonal-f RFF351(a)DiscEMD Serono, Inc.
2020-05-01R001Gonal-f RFF351(a)DiscEMD Serono, Inc.
2020-05-01R002Gonal-f RFF351(a)RxEMD Serono, Inc.
2020-05-01R003Gonal-f RFF351(a)DiscEMD Serono, Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2026-04-01001Gonal-f RFF351(a)DiscVoluntarily Revoked2004-03-25
2026-04-01002Gonal-f RFF351(a)DiscVoluntarily Revoked2004-03-25
2026-04-01003Gonal-f RFF351(a)DiscVoluntarily Revoked2004-03-25
2020-05-01001Gonal-f RFF351(a)DiscLicensed2004-03-25
2020-05-01002Gonal-f RFF351(a)RxLicensed2004-03-25
2020-05-01003Gonal-f RFF351(a)DiscLicensed2004-03-25